ANTIPLATELET THERAPY
Clinical trials for ANTIPLATELET THERAPY explained in plain language.
Never miss a new study
Get alerted when new ANTIPLATELET THERAPY trials appear
Sign up with your email to follow new studies for ANTIPLATELET THERAPY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart stent patients: could a tailored blood thinner dose prevent clots and bleeding?
Disease control Recruiting nowThis study looks for the best type and dose of blood thinner (P2Y12 inhibitor) for people who have had a heart stent placed. After an initial period on two blood thinners, patients switch to one. The goal is to find a dose that keeps blood clotting at a safe level—not too high (w…
Matched conditions: ANTIPLATELET THERAPY
Phase: PHASE3 • Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New blood thinner could make heart bypass safer during surgery
Disease control Recruiting nowThis study is testing whether giving the blood thinner cangrelor through a vein during minimally invasive heart bypass surgery is safe and practical. The goal is to prevent dangerous blood clots while the patient is on the operating table. Researchers will compare 30 patients rec…
Matched conditions: ANTIPLATELET THERAPY
Sponsor: Cardiocentro Ticino • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC